S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

IOVA Iovance Biotherapeutics Inc

12.87

0.37 (2.96%)

May 02 2024 - Closed

Delayed by 15 minutes

Confidential Treatment Order (ct Order)

This regulatory filing also includes additional resources:
filename1.pdf

Iovance Biotherapeutics (NASDAQ:IOVA)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Iovance Biotherapeutics Charts.

Iovance Biotherapeutics (NASDAQ:IOVA)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Iovance Biotherapeutics Charts.

Iovance Biotherapeutics, Inc. News

Iovance Biotherapeutics to Host First Quarter 2024 Financial Results Conference Call and Webcast on Thursday, May 9, 2024
Wednesday 1 May 2024 (2 days ago) • GlobeNewswire Inc.

Iovance Biotherapeutics to Present at Upcoming Conferences
Tuesday 30 April 2024 (3 days ago) • GlobeNewswire Inc.

Iovance Biotherapeutics to Present Clinical and Translational Data at 2024 ASCO Annual Meeting
Wednesday 24 April 2024 (1 week ago) • GlobeNewswire Inc.

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Friday 19 April 2024 (2 weeks ago) • GlobeNewswire Inc.

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Friday 22 March 2024 (1 month ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 6 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 5 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 5 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 5 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 5 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 5 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 5 March 2024 (2 months ago) • Edgar (US Regulatory)

More Iovance Biotherapeutics, Inc. News Articles

BlackStar Enterprise (PK)

Voip Pal Com (QB)

Brookmount Explorations (PK)

Trump Media and Technology

Global Developments (PK)

Atacama Resources (PK)

International Star (PK)

Bell Buckle (PK)

Globestar Therapeutics (PK)

CBD of Denver (PK)

Therapeutic Solutions (PK)

Buildablock (PK)

FuelCell Energy

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions